Economic impact of genomic diagnostics for intermediate‐risk acute myeloid leukaemia

Economic impact of genomic diagnostics for intermediate‐risk acute myeloid leukaemia

Acute Myeloid Leukaemia (AML) is a rare but serious group of diseases that require critical decision-making for curative treatment. Over the past decade, scientific discovery has revealed dozens of prognostic gene mutations for AML while sequencing costs have plummeted. In this study, we compared th...

Полное описание

Библиографические подробности
Главные авторы:	Cressman, S, Karsan, A, Hogge, DE, McPherson, E, Bolbocean, C, Regier, DA, Peacock, SJ
Формат:	Journal article
Язык:	English
Опубликовано:	Wiley 2016

Схожие документы

Quality of life and socioeconomic indicators associated with survival of myeloid leukemias in Canada
по: Sonya Cressman, и др.
Опубликовано: (2020-07-01)

Hypocellular Acute Myeloid Leukaemia-A Diagnostic Conundrum
по: Sindhura Lakshmi Koulmane Laxminarayana, и др.
Опубликовано: (2018-12-01)

Acute Myeloid Leukaemia with Plasmacytosis
по: Yasmin Akhtar, Saqib Qayyum Ahmad, Shahid Jamal
Опубликовано: (2016-12-01)

Exploring the acute myeloid leukaemias
по: TB Thapa
Опубликовано: (2013-10-01)

Secondary acute myeloid leukaemia in children treated for acute lymphoblastic leukaemia.
по: Eden, O, и др.
Опубликовано: (1998)

Acute myeloid leukaemia with aberrant expression of pancytokeratin: A diagnostic pitfall
по: Yasin Dhonye, и др.
Опубликовано: (2023-02-01)

DISTINCTION BETWEEN ACUTE MYELOID LEUKAEMIA WITH MYELODYSPLASIA-RELATED CHANGES AND MIXED-PHENOTYPE ACUTE LEUKAEMIA: A DIAGNOSTIC CHALLENGE
по: NA Marcondes, и др.
Опубликовано: (2021-10-01)

Harnessing the graft-versus-leukaemia effect in acute myeloid leukaemia
по: Sweeney, C
Опубликовано: (2021)

Adhesion Deregulation in Acute Myeloid Leukaemia
по: Alicja M. Gruszka, и др.
Опубликовано: (2019-01-01)

Wnt Signalling in Acute Myeloid Leukaemia
по: Alicja M. Gruszka, и др.
Опубликовано: (2019-11-01)

Orbital deposit in acute myeloid leukaemia
по: Seal G, и др.
Опубликовано: (1973-01-01)

Prediction of acute myeloid leukaemia risk in healthy individuals
по: Abelson, S, и др.
Опубликовано: (2018)

Humoral detection of leukaemia-associated antigens in presentation acute myeloid leukaemia.
по: Guinn, B, и др.
Опубликовано: (2005)

Microcosting analysis of haematopoietic stem cell transplantation and chemotherapy with intermediate doses of cytarabine in the treatment of acute myeloid leukaemia
по: Sitânia Chiesa, и др.
Опубликовано: (2024-12-01)

Amplification of mitochondrial DNA in acute myeloid leukaemia.
по: Boultwood, J, и др.
Опубликовано: (1996)

Immunological weapons against acute myeloid leukaemia.
по: Galea-Lauri, J
Опубликовано: (2002)

C/EBPalpha mutations in acute myeloid leukaemias.
по: Nerlov, C
Опубликовано: (2004)

EVI1 expression in acute myeloid leukaemia.
по: Langabeer, SE, и др.
Опубликовано: (2001)

New Therapeutic Approaches for Acute Myeloid Leukaemia
по: Ruth M Risueno, и др.
Опубликовано: (2021-06-01)

Acute Myeloid Leukaemia Presenting as Gaze Palsy
по: Evripidis Sykakis, и др.
Опубликовано: (2011-11-01)

Pharmacogenomics and regulation of apoptosis in acute myeloid leukaemia
по: Pravdić Zlatko, и др.
Опубликовано: (2020-01-01)

Azacitidine for the treatment of myelodysplastic syndrome, chronic myelomonocytic leukaemia and acute myeloid leukaemia
по: R Edlin, и др.
Опубликовано: (2010-05-01)

Azacitidine for the treatment of myelodysplastic syndrome, chronic myelomonocytic leukaemia and acute myeloid leukaemia
по: R Edlin, и др.
Опубликовано: (2010-05-01)

Expression of Aberrant Markers and its Association with Remission Postinduction Therapy in Acute Lymphoblastic Leukaemia and Acute Myeloid Leukaemia
по: Subbaramaiah Shwetha, и др.
Опубликовано: (2021-07-01)

P580: THE USE OF LEUKAEMIA Q-FUSION GENE SCREENING ASSAY (Q30) IN THE DIAGNOSTIC EVALUATION OF ACUTE MYELOID LEUKAEMIA (AML)
по: S. Tayabali, и др.
Опубликовано: (2022-06-01)

From genomics to targeted treatment in haematological malignancies: a focus on acute myeloid leukaemia
по: Jakobsen, N, и др.
Опубликовано: (2018)

OUTCOME OF CHEMOTHERAPY IN NON ACUTE PROMYELOCYTIC ACUTE MYELOID LEUKAEMIA
по: Nighat Shahbaz, и др.
Опубликовано: (2020-10-01)

OUTCOME OF CHEMOTHERAPY IN NON ACUTE PROMYELOCYTIC ACUTE MYELOID LEUKAEMIA
по: Nighat Shahbaz, и др.
Опубликовано: (2020-10-01)

Low expression of the putative tumour suppressor gene gravin in chronic myeloid leukaemia, myelodysplastic syndromes and acute myeloid leukaemia.
по: Boultwood, J, и др.
Опубликовано: (2004)

Less utilized prognostic markers in acute myeloid leukaemia
по: Abdullah, Maha
Опубликовано: (2016)

Improved outcome of acute myeloid leukaemia in Down's syndrome.
по: Craze, J, и др.
Опубликовано: (1999)

Randomised studies in acute myeloid leukaemia: the double truth
по: Richards, S
Опубликовано: (2000)

Detection of Cup-like Blasts in Acute Myeloid Leukaemia
по: Supriya Mehrotra, и др.
Опубликовано: (2019-10-01)

Phlegmonous gastritis as the initial presentation of acute myeloid leukaemia
по: Shin Lee, и др.
Опубликовано: (2022-08-01)

Chronic myeloid leukaemia presenting as acute pulmonary thromboembolism
по: Shetty Mallikarjuna, и др.
Опубликовано: (2022-01-01)

Granulocytic Sarcoma in an Adult with Relapsed Acute Myeloid Leukaemia
по: Neethu Ann Kurien, и др.
Опубликовано: (2016-01-01)

Unilateral proptosis: extramedullary manifestation of acute myeloid leukaemia
по: Pallavi Gahlowt, и др.
Опубликовано: (2016-03-01)

Clinico-haematological and Cytochemical Study of Acute Myeloid Leukaemia
по: Anil Meena, и др.
Опубликовано: (2020-10-01)

Transcriptional Regulation by the NFAT Family in Acute Myeloid Leukaemia
по: Shaun D. Patterson, и др.
Опубликовано: (2021-08-01)

ENPP4 and HOXA3 as potential leukaemia stem cell markers in acute myeloid leukaemia
по: Mohd Amin, A, и др.
Опубликовано: (2023)